Im
Imvax
Philadelphia PAFounded 201630 employees
Private CapbiotechPrivateOncology
Platform: Auto Tumor Imm
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IMV-6752 | IMV-6752 | Phase 2 | 2 | CDK2 | FLCholangiocarcinoma | ||
| IMV-6044 | IMV-6044 | Phase 1/2 | 2 | BCMA | Ewing SarcomaFL | ||
| Tixazanubrutinib | IMV-4747 | Approved | 2 | GPRC5D | PTSD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)